- Home
- TLF vs KZR Comparison
TLF vs KZR Comparison
Compare TLF & KZR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TLF
- KZR
- Stock Information
- Founded
- TLF 1980
- KZR 2015
- Country
- TLF United States
- KZR United States
- Employees
- TLF N/A
- KZR N/A
- Industry
- TLF Apparel
- KZR Biotechnology: Pharmaceutical Preparations
- Sector
- TLF Consumer Discretionary
- KZR Health Care
- Exchange
- TLF Nasdaq
- KZR Nasdaq
- Market Cap
- TLF 42.8M
- KZR 44.1M
- IPO Year
- TLF N/A
- KZR 2018
- Fundamental
- Price
- TLF $3.12
- KZR $5.85
- Analyst Decision
- TLF
- KZR Hold
- Analyst Count
- TLF 0
- KZR 2
- Target Price
- TLF N/A
- KZR $9.00
- AVG Volume (30 Days)
- TLF 56.5K
- KZR 31.7K
- Earning Date
- TLF 02-26-2025
- KZR 03-17-2025
- Dividend Yield
- TLF N/A
- KZR N/A
- EPS Growth
- TLF N/A
- KZR N/A
- EPS
- TLF 0.09
- KZR N/A
- Revenue
- TLF $74,391,000.00
- KZR N/A
- Revenue This Year
- TLF N/A
- KZR N/A
- Revenue Next Year
- TLF N/A
- KZR N/A
- P/E Ratio
- TLF $32.89
- KZR N/A
- Revenue Growth
- TLF N/A
- KZR N/A
- 52 Week Low
- TLF $2.96
- KZR $5.20
- 52 Week High
- TLF $5.48
- KZR $10.40
- Technical
- Relative Strength Index (RSI)
- TLF 23.37
- KZR 47.61
- Support Level
- TLF $2.96
- KZR $5.65
- Resistance Level
- TLF $3.46
- KZR $6.29
- Average True Range (ATR)
- TLF 0.19
- KZR 0.32
- MACD
- TLF -0.05
- KZR 0.01
- Stochastic Oscillator
- TLF 1.80
- KZR 50.56
About TLF Tandy Leather Factory Inc.
Tandy Leather Factory Inc is a specialty retailers of leather and leathercraft-related items. Its primary line of business is the sale of leather, leather crafts, and related supplies. Its broad line of leather and related products includes leather, leatherworking tools, leather dyes and finishes, and do-it-yourself kits. Its products include Leather, tools, Hardware, Supplies, Kits, Books and Patterns, and Gift cards. The company sells its products primarily through company-owned stores and through orders generated from its global websites, and through direct account representatives in its commercial division. Geographically the company operates within the United States, Canada and others and generates the highest revenue from the United States.
About KZR Kezar Life Sciences Inc.
Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. The pipeline consist of product candidates such as Zetomipzomib (KZR-616), and KZR-261.